![]()
|
|
||||||||
J. Biol. Chem., Vol. 266, Issue 32, 21509-21514, Nov, 1991
J Balzarini, CK Lee, P Herdewijn and E De Clercq
Ribavirin enhances the anti-human immunodeficiency virus activity of
2',3'-dideoxyinosine (ddIno) in MT-4, CEM and peripheral blood lymphocyte
cells. Ribavirin causes an increase in the levels of IMP, the presumed
phosphate donor for the conversion of ddIno to ddIMP by 5'- nucleotidase.
Consequently, ribavirin stimulates the conversion of ddIno to its
antivirally active metabolite ddATP. Ribavirin also causes a marked
depletion of the guanine nucleotide pools. The increase in IMP pool levels
may result from (i) a direct inhibitory effect of ribavirin
5'-monophosphate on IMP dehydrogenase (which converts IMP to XMP) and (ii)
an indirect inhibition of adenylosuccinate synthetase by the decreased GTP
and dGTP pools (since GTP is an obligatory cofactor in the conversion of
IMP to succinyl AMP). GTP depletion plays a key role in the accumulation of
IMP and the resultant higher rate of ddIno phosphorylation to ddIMP and
eventually ddATP. Our findings are in agreement with the observations that
guanosine and 2'-deoxyguanosine, but not 2'-deoxyadenosine, reverse (i) the
stimulatory effect of ribavirin on the anti-human immunodeficiency virus
activity of ddIno and (ii) the accumulation of endogenous IMP pools as well
as accumulation of [3H]IMP from exogenous [3H]hypoxanthine in ribavirin-
treated cells.
Mechanism of the potentiating effect of ribavirin on the activity of 2',3'-dideoxyinosine against human immunodeficiency virus
Rega Institute for Medical Research, Katholieke Universiteit Leuven, Belgium.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
K. Borroto-Esoda, F. Myrick, J. Feng, J. Jeffrey, and P. Furman In Vitro Combination of Amdoxovir and the Inosine Monophosphate Dehydrogenase Inhibitors Mycophenolic Acid and Ribavirin Demonstrates Potent Activity against Wild-Type and Drug-Resistant Variants of Human Immunodeficiency Virus Type 1 Antimicrob. Agents Chemother., November 1, 2004; 48(11): 4387 - 4394. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Metz, S. Holland, L. Johnson, E. Espling, M. Rabaglia, V. Segu, J. S. Brockenbrough, and P. O. Tran Inosine-5'-Monophosphate Dehydrogenase Is Required for Mitogenic Competence of Transformed Pancreatic {beta} Cells Endocrinology, January 1, 2001; 142(1): 193 - 204. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Neyts, G. Andrei, and E. De Clercq The Antiherpesvirus Activity of H2G [(R)-9-[4-Hydroxy-2-(Hydroxymethyl)Butyl]Guanine] Is Markedly Enhanced by the Novel Immunosuppressive Agent Mycophenolate Mofetil Antimicrob. Agents Chemother., December 1, 1998; 42(12): 3285 - 3289. [Abstract] [Full Text] |
||||
![]() |
J. Neyts, G. Andrei, and E. De Clercq The Novel Immunosuppressive Agent Mycophenolate Mofetil Markedly Potentiates the Antiherpesvirus Activities of Acyclovir, Ganciclovir, and Penciclovir In Vitro and In Vivo Antimicrob. Agents Chemother., February 1, 1998; 42(2): 216 - 222. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |